PCV13 was associated with reduced risk for pneumonia hospitalization among older adults in long-term care facilities.

Adults who are admitted to the hospital are often inappropriately diagnosed with — and treated for — pneumonia, new research suggests. These misdiagnosed adults almost always receive a full course of ...

Political bluster about vaccines has arrived along with the season for getting vaccinated against diseases that can lead to ...

Merck (NYSE:MRK) announced late-stage trial data on Thursday suggesting that its Capvaxive vaccine, indicated for adults to prevent invasive pneumococcal disease and pneumonia, is also effective in ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Mortality rates among ICU patients aged ...

In today’s Health Alert, a new study shows that one dose of the RSV vaccine may protect older adults through not just one, ...

RAHWAY, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced results from STRIDE-8, a Phase 3 trial evaluating CAPVAXIVE™ (Pneumococcal ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the U.S. Centers for Disease Control and Prevention’s (CDC’s) Advisory ...

The FDA approved a 21-valent pneumococcal conjugate vaccine (Capvaxive) for preventing invasive pneumococcal disease and pneumococcal pneumonia in adults, Merck announced on Monday. Specifically ...

The U.S. may or may not be headed for a “tripledemic” scenario like it saw last year—one in which three main pathogens drive up illnesses, hospitalizations, and general misery. The term "tripledemic" ...

When U.S. adults are hospitalized with pneumonia, viruses are more often to blame than bacteria. However, despite current diagnostic tests, neither viruses nor bacteria are detected in the majority of ...

Results from the Phase 3 STRIDE-13 trial presented at the 6th ESCMID Conference on VaccinesMerck to share STRIDE-13 results with global regulatory authoritiesRAHWAY, N.J.--(BUSINESS WIRE)--$MRK ...